Vioxx appeal to go before New Jersey court

The New Jersey Supreme Court reportedly has agreed to hear Merck & Co.'s appeal of the class certification of a Vioxx lawsuit.

The Wall Street Journal, quoting a Merck spokesman, reported the suit, brought by a union and several other third-party payers, seeks reimbursement for up to $9.6 billion of Vioxx purchases.

The lawsuit was certified as a class action petition last July and later upheld by a state appellate court. Whitehouse Station, N.J.-based Merck then appealed to the state Supreme Court.

Vioxx was taken off the market in September 2004 after a study linked the painkiller to an increased risk of heart attack and stroke. Since then more than 14,000 lawsuits have been filed against the company, the report said.

Under New Jersey's rigorous consumer laws, awards in such cases can be tripled, the Journal said.

Copyright 2006 by United Press International


Explore further

Merck pays $830 M to settle class-action case over Vioxx

Citation: Vioxx appeal to go before New Jersey court (2006, July 25) retrieved 23 September 2020 from https://phys.org/news/2006-07-vioxx-appeal-jersey-court.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments